REVOLVING CREDIT NOTERevolving Credit Note • July 1st, 2002 • Hauser Inc • Medicinal chemicals & botanical products
FOR VALUE RECEIVED, the undersigned, HAUSER, INC., a Delaware corporation, HAUSER TECHNICAL SERVICES, INC., a Delaware Corporation, BOTANICALS INTERNATIONAL EXTRACTS, INC., a Delaware corporation, ZETAPHARM, INC., a New York corporation, (collectively, the "Borrowers"), hereby jointly and severally, unconditionally promise to pay to the order of Wells Fargo Bank, National Association (the "Lender"), at c/o Wells Fargo Bank, N.A., 333 South Grand Avenue, 9th Floor, Los Angeles, California 90071, or at such other place as the holder of this Note may direct, on August 31, 2002 (the "Maturity Date") in lawful money of the United States of America and in immediately available funds, the principal amount of (a) TEN MILLION SEVEN HUNDRED FIFTY THOUSAND DOLLARS ($10,750,000), or (B) such other amount as represents the aggregate unpaid principal amount of all Revolving Loans made by the Lender pursuant to the Credit Agreement (referred to below). The Borrowers further agree, jointly and several
WAIVER AND AMENDMENT --------------------Credit Agreement • July 1st, 2002 • Hauser Inc • Medicinal chemicals & botanical products
TERM NOTETerm Note • July 1st, 2002 • Hauser Inc • Medicinal chemicals & botanical products
This Note amends, restates and replaces the Term Note previously issued by Borrower and referred to in the Amended and Restated Credit Agreement by and between the Borrower and the Lender dated as of December 7, 2001, as amended (the "Credit Agreement"), is secured as provided therein and in the Security Documents and is subject to optional and mandatory prepayment as set forth in the Credit Agreement.
